| Quarter | Score |
|---|---|
| 2022-Q1 | 50.9 |
| 2022-Q3 | 65.6 |
| 2022-Q4 | 49.3 |
| 2023-Q1 | 49.2 |
| 2023-Q2 | 63.6 |
| 2023-Q3 | 48.1 |
| 2023-Q4 | 65.7 |
| 2024-Q1 | 49.7 |
| 2024-Q2 | 44.9 |
| 2024-Q3 | 87.6 |
| 2024-Q4 | 86.0 |
| 2025-Q1 | 86.0 |
| 2025-Q2 | 85.9 |
| 2025-Q3 | 85.9 |
| 2025-Q4 | 86.0 |
| 2026-Q1 | 86.1 |
| 2026-Q2 | 86.1 |
Strong consensus, but price is extended — wait for pullback to funds' basis
Trading +61.0% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold EWBC. Avg conviction: 4.8%. Net adding. First tracked at $77.99 (current +61.0% vs tracked).
Himalaya Capital Management has 9.7% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Himalaya Capital Management | 9.7% | Hold |
| Citadel Advisors | 0.0% | Add |